Why Catalent Stock Zoomed 12% Higher This Week
(NYSE: CTLT) is one company that probably wishes the summer would never end. As August came to a close, the contract drug manufacturer's stock enjoyed a nearly 12% rise over the course of the month's final week. That's according to data compiled by S&P Global Market Intelligence.
Catalent's happy week kicked off on Tuesday, when the company unveiled its preliminary fourth-quarter and full-year 2023 results. These showed that both revenue and non-GAAP (adjusted) net profit saw year-over-year declines.
Yet expectations for Catalent, which has struggled with a series of production difficulties at three of its factories, were quite low.
Source Fool.com
Catalent Inc. Stock
€52.56
0.340%
The community is currently still undecided about Catalent Inc. with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 55 € shows a slightly positive potential of 4.64% compared to the current price of 52.56 € for Catalent Inc..
